Determination of blood concentration levels of psychotropic medications in Rwandan patients

References

• Hiemke C, Baumann P, Bergemann N, Conca A, Dietmaier O, Egberts K, et al. AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011. Pharmacopsychiatry. 2011;44:195–235.
   Web of Science ®Google Scholar
• Addington D. Best practices: improving quality of care for patients with first-episode psychosis. Psychiatr Serv. 2009;60:1164–6.
   PubMed Web of Science ®Google Scholar
• Baumann P, Hiemke C, Ulrich S, Gaertner I, Rao ML, G, et al. Therapeutic monitoring of psychotropic drugs, an outline of the AGNP-TDM expert group consensus guideline. Ther Drug Monit. 2004;26:167–70.
   PubMed Web of Science ®Google Scholar
• Malhotra AK, Murphy GM, Kennedy JL. Pharmacogenetics of psychotropic drug response. Am J Psychiatry. 2004;161:780–96.
   PubMed Web of Science ®Google Scholar
• Preskorn SH. CNS drug development: part I: the early period of CNS drugs. J Psychiatr Pract. 2010;16:334–9.
   PubMed Web of Science ®Google Scholar
• Preskorn SH. CNS drug development: part II: advances from the 1960s to the 1990s. J Psychiatr Pract. 2010;16:413–5.
   PubMed Web of Science ®Google Scholar
• Bates DW, Gawande AA. Improving safety with information technology. N Engl J Med. 2003;348:2526–34.
   PubMed Web of Science ®Google Scholar
• Touw DJ, Neef C, Thomson AH, Vinks AA. Cost-effectiveness of therapeutic drug monitoring: a systematic review. Ther Drug Monit. 2005;27:10–17.
   PubMed Web of Science ®Google Scholar
• Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, et al. The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry. 2004;37:243–65.
   PubMed Web of Science ®Google Scholar
• Bengtsson F. Therapeutic drug monitoring of psychotropic drugs. TDM “nouveau”. Ther Drug Monit. 2004;26:145–51.
   PubMed Web of Science ®Google Scholar
• Hiemke C. Therapeutic drug monitoring in neuropharmacology: does it hold its promises? Eur Arch Psychiatry Clin Neurosci. 2008;258(Suppl 1):21–7.
   PubMed Web of Science ®Google Scholar
• Hiemke C. Clinical utility of drug measurement and pharmacokinetics therapeutic drug monitoring in psychiatry. Eur J Clin Pharmacol. 2008;64:159–66.
   PubMed Web of Science ®Google Scholar
• Jaquenoud Sirot E, Knezevic B, Morena GP, Harenberg S, Oneda B, Crettol S, et al. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. J Clin Psychopharmacol. 2009;29:319–26.
   PubMed Web of Science ®Google Scholar
• Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67–76.
   PubMed Web of Science ®Google Scholar
• Raggi MA. Therapeutic drug monitoring: chemical-clinical correlations of atypical antipsychotic drugs. Curr Med Chem. 2002;9:1397–409.
   PubMed Web of Science ®Google Scholar
• Preskorn SH, Fast GA. Therapeutic drug monitoring for antidepressants: efficacy, safety, and cost effectiveness. J Clin Psychiatry. 1991;52:23–33.
   PubMed Web of Science ®Google Scholar
• Munyendamutsa N. Plus de 20% des Rwandais sont traumatisés par le Génocide. Rwanda News Agency, 2010, April 7. Available from http://www.rnanews.com/index.php?option=com_content&view=article&id=3111:plus-de-20-des-rwandais-sont-traumatises-par-le-genocide&Itemid=47.
   Google Scholar
• Laux G, Baumann P, Hiemke C. The TDM group of the Arbeitsgemeinschaft Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP), Therapeutic drug monitoring of antidepressants-clinical aspects. J Neural Transm Suppl. 2007;72:261–7.
   PubMedGoogle Scholar
• Gaillard Y, Pépin G. Use of high performance liquid chromatography with photodiode array UV detection for creation of a 600-compound library: application to forensic toxicology. J Chromatogr A. 1996;763:149–63.
   Web of Science ®Google Scholar
• Hahirwa I, Charlier C, Denooz R, Karangwa C. Validation of analytical method for the determination in serum of psychotropic drugs commonly prescribed in Rwanda by HPLC-DAD. Acta Clin Belg. 2013;68(6):479.
   Web of Science ®Google Scholar
• Wu HBA. Tietz clinical guide to laboratory tests. 4th edn. St-Louis, MO: Saunders; 2006.
   Google Scholar
• Bauer LA. Applied clinical pharmacokinetics. 2nd ed. University of Washington, Schools of Pharmacy and Medicine; Seattle, 2008.
   Google Scholar
• Demyttenaere K. Risk factors and predictors of compliance in depression. Eur Neuropsychopharmacol. 2003;13:69–75.
   PubMed Web of Science ®Google Scholar
• Mitchell PB. Therapeutic drug monitoring of psychotropic medications. Br J Pharmacol. 2001;52:45–54.
   Web of Science ®Google Scholar
• Akerblad AC, Bengtsson F, Ekselius L, von Knorring L. Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners. Int Clin Psychopharmacol. 2003;18:347–54.
   PubMed Web of Science ®Google Scholar
• Beasley CM Jr, Stauffer VL, Liu-Seifert H, Taylor CC, Dunayevich E, Davis JM. All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysis. J Clin Psychopharmacol. 2007;27:252–8.
   PubMed Web of Science ®Google Scholar
• Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand. 2002;105:164–72.
   PubMed Web of Science ®Google Scholar
• Charlier C, Pinto E, Ansseau M, Plomteux G. Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine, clomipramine, paroxetine or venlafaxine. Hum Psychopharmacol. 2000;15(6):453–9.
   PubMed Web of Science ®Google Scholar
• Katon W, Cantrell CR, Sokol MC, Chiao E, Gdovin JM. Impact of antidepressant drug adherence on comorbid medication use and resource utilization. Arch Intern Med. 2005;165:2497–503.
   PubMed Web of Science ®Google Scholar
• Pfuhlmann B, Gerlach M, Burger R, Gonska S, Unterecker S, Jabs B, et al. Therapeutic drug monitoring of tricyclic antidepressants in everyday clinical practice. J Neural Transm Suppl. 2007;72:287–96.
   PubMedGoogle Scholar
• Frackiewicz EJ, Jhee SS, Shiovitz TM, editors. Ethnicity in drug development and therapeutics. Cambridge: Cambridge University Press; 2011.
   Google Scholar
• Ulrich S, Neuhof S, Braun V, Meyer FP. Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder. Pharmacopsychiatry. 1998;31(5):163–9.
   PubMed Web of Science ®Google Scholar
• Brøsen K. Drug-metabolizing enzymes and therapeutic drug monitoring in psychiatry. Ther Drug Monit. 1996;18(4):393–6.
   PubMed Web of Science ®Google Scholar
• Müller MJ, Dragicevic A, Fric M, Gaertner I, Grasmäder K, Härtter S, et al. Therapeutic drug monitoring of tricyclic antidepressants: how does it work under clinical conditions? Pharmacopsychiatry. 2003;36(3):98–104.
   PubMed Web of Science ®Google Scholar